Fiche centre
Brigham and Women's Hospital
Boston — United States
Essais liés37clinical trials
VilleBostonlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT03141684
Essais cliniques associés
37| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Empagliflozin 10 MG | Maladie rénale chronique | Phase 2 | NCT05786443 | SEED — Safety and Efficacy of Empagliflozin in Hemodialysis | ACTIVE_NOT_RECRUITING |
| Dapagliflozin (10Mg Tab) along with standard medical therapy | Lupus | Phase 4 | NCT07323524 | Dapa-Active LN — Dapagliflozin in Active Lupus Nephritis | RECRUITING |
| Survodutide | Maladie rénale chronique | Phase 3 | NCT06077864 | A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT) | COMPLETED |
| Impella | Maladie coronarienne | À vérifier | NCT06964685 | OASIS-AMICS — Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock | RECRUITING |
| J-Valve Transfemoral System | Maladie coronarienne | Non applicable | NCT07363473 | JOURNEY LVAD: JOURNEY Left Ventricular Assist Device | ACTIVE_NOT_RECRUITING |
| IV acetaminophen | Maladie coronarienne | Phase 3 | NCT04093219 | PANDORA: Delirium Prevention After Cardiac Surgery Using IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients | COMPLETED |
| Relative Blood Volume Monitoring (RBVM) | Maladie rénale chronique | À vérifier | NCT07866872 | Blood Volume Monitoring Via Critline in Volume Overload: Hospitalization and Readmission | ENROLLING_BY_INVITATION |
| WATCHMAN FLX LAAC Device | Accident vasculaire cérébral | Non applicable | NCT04394546 | CHAMPION-AF Clinical Trial | ACTIVE_NOT_RECRUITING |
| AFSW Guided DOAC | Accident vasculaire cérébral | Phase 3 | NCT05836987 | REACT-AF — The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation | RECRUITING |
| Daily Voice Recording | Insuffisance cardiaque | À vérifier | NCT07870395 | VOICE-HF — Voice-based Outcome Identification and Clinical Evaluation in Heart Failure | NOT_YET_RECRUITING |
| Study Subjects | Épilepsie | Non applicable | NCT07877896 | A Device to Prevent Unexpected Death in Epilepsy | ACTIVE_NOT_RECRUITING |
| Acoramidis | Alzheimer | Phase 2 | NCT03536767 | Open-Label Study of AG10 in Patients With Cardiomyopathy | TERMINATED |
| Atezolizumab | Cancer | Phase 2 | NCT03141684 | Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma | ACTIVE_NOT_RECRUITING |
| NaviFUS System | Épilepsie | Phase 1/2 | NCT06388707 | A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy | RECRUITING |
| Nerandomilast | Myopathies | Phase 3 | NCT07789015 | VERANDA™-IIM — A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies | NOT_YET_RECRUITING |
| CABA-201 | Lupus | Phase 1/2 | NCT06121297 | RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus | RECRUITING |
| Emtricitabine and tenofovir disoproxil fumarate combination | Alzheimer | Phase 1 | NCT07795307 | Repurposing a Combination Antiretroviral Drug Therapy to Target Retrotransposons and Treat Early Alzheimer's Disease | NOT_YET_RECRUITING |
| Donanemab | Alzheimer | Phase 3 | NCT04437511 | A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) | ACTIVE_NOT_RECRUITING |
| Immune Profiling During Ocrelizumab Treatment in Multiple Sclerosis | SEP | À vérifier | NCT03138525 | Immune Profiling During Ocrelizumab Treatment in Multiple Sclerosis | COMPLETED |
| PF-07799544 | Cancer | Phase 1 | NCT05538130 | A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors | RECRUITING |
| CORAL — Cocoa Extract for Migraine Trial | Migraine | Non applicable | NCT06808230 | CORAL — Cocoa Extract for Migraine Trial | RECRUITING |
| Descartes-08 | Myopathies | Phase 2 | NCT07391605 | Descartes-08 in Autoantibody Myositis | RECRUITING |
| Neuraceq | Alzheimer | À vérifier | NCT05617014 | ADNI4 — Alzheimer's Disease Neuroimaging Initiative 4 | ENROLLING_BY_INVITATION |
| Study Subjects | Épilepsie | Non applicable | NCT06135285 | A Device to Prevent Sudden Unexpected Death in Epilepsy: Detecting Peri-Ictal Body Position | NOT_YET_RECRUITING |
| Acoramidis | Alzheimer | Phase 3 | NCT06563895 | Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant | RECRUITING |
| Mycophenolate Mofetil | Myasthénie | À vérifier | NCT03490539 | PROMISE-MG — Disease-Modifying Treatments for Myasthenia Gravis | COMPLETED |
| Litifilimab | Lupus | Phase 2/3 | NCT05531565 | AMETHYST — A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus | ACTIVE_NOT_RECRUITING |
| XEN1101 | Épilepsie | Phase 3 | NCT05718817 | X-TOLE4 — An Open-label Study of XEN1101 in Epilepsy | ENROLLING_BY_INVITATION |
| CT1812 | Alzheimer | Phase 2 | NCT05531656 | A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease | ACTIVE_NOT_RECRUITING |
| ADNI-GO — Alzheimer's Disease Neuroimaging Initiative Grand Opportunity | Alzheimer | À vérifier | NCT01078636 | ADNI-GO — Alzheimer's Disease Neuroimaging Initiative Grand Opportunity | COMPLETED |
| Robotic-Assisted Surgery | Myasthénie | Non applicable | NCT05150210 | SP Thoracic IDE Study | ACTIVE_NOT_RECRUITING |
| Ocrelizumab | SEP | À vérifier | NCT05131984 | Ocrelizumab Access by Socio-Economic Status | COMPLETED |
| Bevacizumab | Cancer | Phase 2 | NCT00861705 | Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery | COMPLETED |
| Foralumab | SEP | Phase 2 | NCT06292923 | A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients | ACTIVE_NOT_RECRUITING |
| Foralumab TZLS-401 100 µg | SEP | Phase 2 | NCT06890923 | TILS-022 — Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis | RECRUITING |
| Foralumab TZLS-401 50 µg | SEP | À vérifier | NCT06802328 | Intermediate-Size Patient Population Expanded Access: Foralumab in Non-Active Secondary Progressive MS Patients | AVAILABLE |
| A Study of Brain Aging in Vietnam War Veterans | Alzheimer | À vérifier | NCT01687153 | A Study of Brain Aging in Vietnam War Veterans | COMPLETED |